To evaluate the suitability (i.e. number of tests completed and number of participants completing the tests, variance estimate of baseline and of the change from baseline values) of neurocognitive tests and functioning scales in view of their use in future multicenter, multinational clinical efficacy trials testing a putative cognitive enhancer for individuals with Down syndrome aged 6-30.
Study Type
OBSERVATIONAL
Enrollment
43
Unnamed facility
Sapporo, Hokkaido, Japan
Unnamed facility
Yokohama, Kanagawa, Japan
Unnamed facility
Izumi, Osaka, Japan
Unnamed facility
Takatsuki, Osaka, Japan
Unnamed facility
Suitability for individuals with Down syndrome assessed by number of tests completed and number of participants completing the tests, variance estimate of baseline and of the change from baseline values.
Time frame: 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Saitama, Saitama, Japan
Unnamed facility
Chiyoda-ku, Tokyo, Japan
Unnamed facility
Setagaya-ku, Tokyo, Japan